Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaï¾® SARS…
On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…
On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…
On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…
On Aug. 17, 2020, the USDA National Veterinary Services Laboratories (NVSL) announced the first confirmed cases of SARS-CoV-2…
On Aug. 17, 2020, PerkinElmer announced the launch of a series of explorerï¾™ workstations for SARS-CoV-2 testing capable…
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…
On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Aug. 13, 2020, data from the WHO/UNICEF Joint Monitoring Programme (JMP) revealed that 43 per cent of…
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…